Anaplastic Astrocytoma
What's New
Last Posted: Mar 07, 2023
- [Prognostic significance of combined TERT and IDH gene mutation analysis in diffusely infiltrating gliomas].
Liu Q Q, et al. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 0 (9) 658-663 - Cerebellar glioblastoma: a clinical series with contemporary molecular analysis.
Hong Bujung, et al. Acta neurochirurgica 2018 0 (11) 2237-2248 - Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.
Iuchi Toshihiko, et al. Brain tumor pathology 2018 0 (2) 71-80 - Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: a clinicopathological study of 89 cases.
Kwon Mi Jung, et al. Brain pathology (Zurich, Switzerland) 2019 0 (2) 235-245 - Cerebellar anaplastic astrocytoma in adult patients: 15 consecutive cases from a single institution and literature review.
Belyaev Artem, et al. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2021 0 249-254 - Molecular biomarkers and integrated pathological diagnosis in the reclassification of gliomas.
Ruiz María Fernanda, et al. Molecular and clinical oncology 2021 0 (2) 150 - Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.
Tesileanu C Mircea S, et al. Neuro-oncology 2021 0 (9) 1547-1559 - Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma.
Mair Maximilian J, et al. Journal of neuro-oncology 2020 0 (1) 187-198 - Hypermethylation downregulates P2X receptor expression in astrocytoma.
Liu Jing, et al. Oncology letters 2018 0 (6) 7699-7704 - Superiority of temozolomide over radiotherapy for elderly patients with RTK II methylation class, MGMT promoter methylated malignant astrocytoma.
Wick Antje, et al. Neuro-oncology 2020 0 (8) 1162-1172
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Apr 01, 2023
- Content source: